Cancer Therapy

Surgery - Surgery

Surgery

Early-stage cancers have a significantly higher chance of being cured if the tumor can be surgically removed. The surgeon will assess the size and location of the tumor, as well as the patient's overall health, including anesthesia risks, to determine if the patient is a suitable candidate for surgery.

In recent years, advancements in surgical techniques have been evident in the evolution from traditional open abdominal surgery to laparoscopic or robotic-assisted surgery (also known as "minimally invasive surgery"). As the name suggests, minimally invasive surgery reduces surgical trauma, while also minimizing the risk of blood loss and complications during surgery; smaller incisions lead to faster postoperative recovery, and shorter hospital stays.

Some patients require adjuvant therapy after surgery, including chemotherapy and/or radiation therapy, to consolidate the therapeutic effect and reduce the chance of recurrence. This is because cancer cells may have already metastasized to other parts of the body via the lymphatic system or bloodstream before surgery. These extremely small amounts of cancer cells are invisible to the naked eye; they may lie dormant in the body and, given time, become active again and grow uncontrollably, leading to recurrence. Postoperative adjuvant therapy aims to further eliminate any remaining cancer cells in the patient's body, minimizing the chance of recurrence.

Related Articles

Doctor Updates

癌症患者免疫力下降易生蛇,症狀包括神經痛、水泡,易與癌症痛症混淆。李宇聰醫生建議化療前接種新一代重組生蛇疫苗,非活體疫苗更安全,保護率87.7%,保護期11年。發病72小時內服抗病毒藥可減輕症狀。香港聯合腫瘤中心提供疫苗諮詢、接種及治療服務,助患者預防生蛇。

Cancer patients are prone to severe sequelae of snakes| Early vaccination reduces risk-Professional analysis by Dr. Li Yu Chung, Jacky

Cancer patients have reduced immunity and are prone to snakes. Symptoms include neuralgia and blisters, which are easily confused with cancer pain. Dr. Li Yu Chung, Jacky recommends that a new generation of recombinant snake vaccine be vaccinated before chemotherapy. Non-live vaccines are safer, with a protection rate of 87.7% and a protection period of 11 years. Taking antiviral drugs within 72 hours of the onset of the disease can reduce symptoms. The United Cancer Centre of Hong Kong provides vaccine consultation, vaccination and treatment services to help patients prevent cancer.

第四期肺癌康復奇蹟|鍾喜英HER2基因突變成功治療個案 - 李宇聰醫生解析基因檢測重要性

Stage 4 Lung Cancer Recovery Miracle | A Successful Treatment Case of HER2 Gene Mutation

Ms. Zhong Xiying was diagnosed with multiple metastases of stage 4 lung cancer in the brain, liver and bone, and once wanted to give up treatment. Dr. Li Yu Chung, Jacky insisted on genetic testing to find rare HER2 mutations, and quickly formulated a personalized targeted treatment plan to successfully control the condition. Real cases share how genetic testing has changed destiny, and now Ms. Zhong can travel with her family and enjoy happiness. The United Cancer Centre of Hong Kong provides comprehensive genetic testing and personalized treatment services.

台灣男星顏正國肺腺癌離世,確診不足1年。香港聯合腫瘤中心李宇聰醫生解析本港肺癌致命率達66%,每年5,707人確診。詳解6大高危人士、3種警號徵狀、4大治療方案及存活率。第一期治癒率達90%,及早篩查是關鍵。提供標靶治療、免疫治療及LDCT肺癌篩查服務。

Yen Cheng-kuo passed away from lung adenocarcinoma | Dr. Li Yu Chung, Jacky analyzes 6 high-risk factors, survival rates, and the latest treatment options

Taiwanese male star Yan Zhengguo passed away from pulmonary adenocarcinoma, less than 1 year after his diagnosis. According to an analysis by Dr. Li Yu Chung, Jacky of the United Cancer Centre of Hong Kong, the fatal rate of lung cancer in Hong Kong is 66%, with 5,707 people diagnosed each year. Detailed description of 6 high-risk persons, 3 warning signs, 4 treatment options and survival rates. The treatment rate in the first phase is 90%, and early screening is the key. Provide targeted therapy, immunotherapy and LDCT lung cancer screening services.

2025年9月18日 宏利健康講座:肺癌、乳癌及前列腺癌治療新趨勢 - 香港聯合腫瘤中心李宇聰醫生分享

Manulife Health Seminar, September 18, 2025: New Trends in the Treatment of Lung Cancer, Breast Cancer, and Prostate Cancer – Dr. Li Yu-chung of the Hong Kong United Oncology Centre shares his insights.

On September 18, 2025, Dr. Li Yu Chung, Jacky of the Department of Clinical Oncology at the Hong Kong United Oncology Centre (HKUOC) will share the latest treatment trends in lung cancer, breast cancer, and prostate cancer at the Manulife Health Seminar. The seminar will be held at Manulife Tower in Kwun Tong from 10:30 a.m. to 11:30 a.m. All are welcome to attend and learn about the cutting-edge treatment technologies and personalized plans!

2025年10月17日,香港聯合腫瘤中心(HKUOC)聯同香港腫瘤學研究學會(HKOSG)於佐敦盛樂中心成功舉辦「肺癌精準治療 基因檢測改寫生命」講座,吸引超過百位肺癌患者、康復者及家屬參與。主講嘉賓為臨床腫瘤科專科李宇聰醫生,講座深入介紹基因檢測技術如何為肺癌患者帶來新希望。

A new era of precision treatment of lung cancer: Genetic Testing rewrites the Story of life|Cancer Lecture series (2025/10/17)

On October 17, 2025, the United Cancer Centre of Hong Kong (HKUOC) and the Hong Kong Society of Oncology Research (HKOSG) successfully held a seminar on "Precision Treatment of Lung Cancer Genetic Testing Rewrites Life" at the Jordan Shing Lok Centre, attracting more than 100 lung cancer patients, survivors and their families to participate. The keynote speaker was Dr. Li Yu Chung, Jacky, a specialist in clinical oncology. The lecture introduced in depth how genetic testing technology can bring new hope to lung cancer patients.